Investors
Specialized pharmaceutical company for creating market value through experience and innovation
Presentations
Poster presentation at AACR 2023 (TU2218)
Poster presentation of TU2218, an oral immune-oncology therapy targeting TGF-beta and VEGF, at the American Association for Cancer Research (AACR) 2023
